Skip to main content
. 2021 Jan 15;2021(1):CD013198. doi: 10.1002/14651858.CD013198.pub2

16. Serious adverse events: total number of participants and rank statistics for each class (sorted by mean rank).

Treatment class N Mean Median 95% CrI
Macrolide 971 1.33 1 1 to 3
Macrolide + tetracycline 101 2.61 2 1 to 4
Quinolone 569 2.95 3 1 to 4
Pbo 1539 3.12 3 2 to 4

Abbreviations

CrI: credible interval; Pbo: placebo.